Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1985 Nov-Dec;58(6):519–534.

Phototherapy and photopharmacology.

F P Gasparro, G Chan, R L Edelson
PMCID: PMC2589966  PMID: 3832664

Abstract

The activation of 8-methoxypsoralen (8-MOP) by long-wavelength ultraviolet A light (UVA, 320-400 nm) induces the formation of interstrand cross-links in DNA. Psoralen plus UVA (PUVA) is widely used in the treatment of psoriasis, a hyperproliferative disease of the skin. A new psoralen plus UVA therapy has been developed in which the 8-MOP-containing blood of cutaneous T cell lymphoma (CTCL) patients is irradiated with UVA light extracorporeally (i.e., extracorporeal photopheresis). The first group of patients had the leukemic variant of CTCL. A regimen of two treatments on successive days at monthly intervals produced a clinical response in eight of 11 patients. In this review the properties of several psoralens (both naturally occurring and synthetic derivatives) are compared, using several assays (DNA cross-linking, inhibition of lymphocyte response to mitogen stimulation, and cell viability). The development of a panel of monoclonal antibodies that recognize 8-MOP-modified DNA is also described. These antibodies have been used to quantitate 8-MOP photoadduct levels in human DNA samples. In addition to the psoralens, the light activation of two other compounds, gilvocarcin and an insulin-psoralen conjugate, is described.

Full text

PDF
519

Images in this article

524FIG. 4
on p.524

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T. F., Voorhees J. J. Psoralen photochemotherapy of cutaneous disorders. Annu Rev Pharmacol Toxicol. 1980;20:235–257. doi: 10.1146/annurev.pa.20.040180.001315. [DOI] [PubMed] [Google Scholar]
  2. Bayer E. A., Wilchek M. The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal. 1980;26:1–45. doi: 10.1002/9780470110461.ch1. [DOI] [PubMed] [Google Scholar]
  3. Bredberg A. Genetic toxicity of psoralen and ultraviolet radiation in human cells. Acta Derm Venereol Suppl (Stockh) 1982;104:1–40. [PubMed] [Google Scholar]
  4. Bridges B. A. Psoralens and serendipity: aspects of the genetic toxicology of 8-methoxypsoralen. Environ Mutagen. 1983;5(3):329–339. doi: 10.1002/em.2860050311. [DOI] [PubMed] [Google Scholar]
  5. Cole R. S. Light-induced cross-linking of DNA in the presence of a furocoumarin (psoralen). Studies with phage lambda, Escherichia coli, and mouse leukemia cells. Biochim Biophys Acta. 1970 Sep 17;217(1):30–39. doi: 10.1016/0005-2787(70)90119-x. [DOI] [PubMed] [Google Scholar]
  6. Dall'Acqua F., Vedaldi D., Bordin F., Baccichetti F., Carlassare F., Tamaro M., Rodighiero P., Pastorini G., Guiotto A., Recchia G. 4'-Methylangelicins: new potential agents for the photochemotherapy of psoriasis. J Med Chem. 1983 Jun;26(6):870–876. doi: 10.1021/jm00360a016. [DOI] [PubMed] [Google Scholar]
  7. Dall'Acqua F., Vedaldi D., Guiotto A., Rodighiero P., Carlassare F., Baccichetti F., Bordin F. Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA. J Med Chem. 1981 Jul;24(7):806–811. doi: 10.1021/jm00139a008. [DOI] [PubMed] [Google Scholar]
  8. Edelson R. L. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol. 1980 Feb;2(2):89–106. doi: 10.1016/s0190-9622(80)80385-9. [DOI] [PubMed] [Google Scholar]
  9. Elespuru R. K., Gonda S. K. Activation of antitumor agent gilvocarcins by visible light. Science. 1984 Jan 6;223(4631):69–71. doi: 10.1126/science.6229029. [DOI] [PubMed] [Google Scholar]
  10. FITZPATRICK T. B., PATHAK M. A. Historical aspects of methoxsalen and other furocoumarins. J Invest Dermatol. 1959 Feb;32(2 Pt 2):229–231. [PubMed] [Google Scholar]
  11. Gasparro F. P., Berger C. L., Edelson R. L. Effect of monochromatic UVA light and 8-methoxypsoralen on human lymphocyte response to mitogen. Photodermatol. 1984 Feb;1(1):10–17. [PubMed] [Google Scholar]
  12. Gasparro F. P., Saffran W. A., Cantor C. R., Edelson R. L. Wavelength dependence for AMT crosslinking of pBR322 DNA. Photochem Photobiol. 1984 Aug;40(2):215–219. doi: 10.1111/j.1751-1097.1984.tb04578.x. [DOI] [PubMed] [Google Scholar]
  13. Gilchrest B. A. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat Rep. 1979 Apr;63(4):663–667. [PubMed] [Google Scholar]
  14. Hönigsmann H., Jaschke E., Gschnait F., Brenner W., Fritsch P., Wolff K. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis. Br J Dermatol. 1979 Oct;101(4):369–378. doi: 10.1111/j.1365-2133.1979.tb00014.x. [DOI] [PubMed] [Google Scholar]
  15. Isaacs S. T., Shen C. K., Hearst J. E., Rapoport H. Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA. Biochemistry. 1977 Mar 22;16(6):1058–1064. doi: 10.1021/bi00625a005. [DOI] [PubMed] [Google Scholar]
  16. Kanne D., Rapoport H., Hearst J. E. 8-Methoxypsoralen-nucleic acid photoreaction. Effect of methyl substitution on pyrone vs. furan photoaddition. J Med Chem. 1984 Apr;27(4):531–534. doi: 10.1021/jm00370a017. [DOI] [PubMed] [Google Scholar]
  17. Koprowski H., Herlyn D., Lubeck M., DeFreitas E., Sears H. F. Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci U S A. 1984 Jan;81(1):216–219. doi: 10.1073/pnas.81.1.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LERNER A. B., DENTON C. R., FITZPATRICK T. B. Clinical and experimental studies with 8-methoxypsoralen in vitiligo. J Invest Dermatol. 1953 Apr;20(4):299–314. doi: 10.1038/jid.1953.36. [DOI] [PubMed] [Google Scholar]
  19. MUSAJO L. Interessanti proprietà delle furocumarine naturali. Farmaco Sci. 1955;10(8):539–558. [PubMed] [Google Scholar]
  20. Murphy R. F., Bisaccia E., Cantor C. R., Berger C., Edelson R. L. Internalization and acidification of insulin by activated human lymphocytes. J Cell Physiol. 1984 Nov;121(2):351–356. doi: 10.1002/jcp.1041210212. [DOI] [PubMed] [Google Scholar]
  21. Parrish J. A., Fitzpatrick T. B., Tanenbaum L., Pathak M. A. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974 Dec 5;291(23):1207–1211. doi: 10.1056/NEJM197412052912301. [DOI] [PubMed] [Google Scholar]
  22. Raso V., Ritz J., Basala M., Schlossman S. F. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Cancer Res. 1982 Feb;42(2):457–464. [PubMed] [Google Scholar]
  23. Santella R. M., Dharmaraja N., Gasparro F. P., Edelson R. L. Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light. Nucleic Acids Res. 1985 Apr 11;13(7):2533–2544. doi: 10.1093/nar/13.7.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sapeika N. Treatment of psoriasis at the Dead Sea. S Afr Med J. 1976 Nov 27;50(51):2021–2021. [PubMed] [Google Scholar]
  25. Song P. S., Tapley K. J., Jr Photochemistry and photobiology of psoralens. Photochem Photobiol. 1979 Jun;29(6):1177–1197. doi: 10.1111/j.1751-1097.1979.tb07838.x. [DOI] [PubMed] [Google Scholar]
  26. Wei T. T., Byrne K. M., Warnick-Pickle D., Greenstein M. Studies on the mechanism of actin of gilvocarcin V and chrysomycin A. J Antibiot (Tokyo) 1982 Apr;35(4):545–548. doi: 10.7164/antibiotics.35.545. [DOI] [PubMed] [Google Scholar]
  27. Yemul S., Berger C., Estabrook A., Edelson R., Bayley H. The delivery of phototoxic drugs to selected cells. Ann N Y Acad Sci. 1985;446:403–414. doi: 10.1111/j.1749-6632.1985.tb18417.x. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES